CETP Inhibitors - A New Inning?

被引:20
|
作者
Hegele, Robert A. [1 ]
机构
[1] Schulich Sch Med & Dent, Dept Med, London, ON, Canada
关键词
HIGH-RISK;
D O I
10.1056/NEJMe1711407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1284 / 1285
页数:2
相关论文
共 50 条
  • [41] Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol
    Tietjen, Ian
    Hovingh, G. Kees
    Singaraja, Roshni R.
    Radomski, Chris
    Barhdadi, Amina
    McEwen, Jason
    Chan, Elden
    Mattice, Maryanne
    Legendre, Annick
    Franchini, Patrick L.
    Dube, Marie-Pierre
    Kastelein, John J. P.
    Hayden, Michael R.
    PLOS ONE, 2012, 7 (08):
  • [42] Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases
    Girona, Josefa
    Ibarretxe, Daiana
    Plana, Nuria
    Guaita-Esteruelas, Sandra
    Amigo, Nuria
    Heras, Mercedes
    Masana, Luis
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [43] Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9
    van der Tuin, Sam J. L.
    Kuhnast, Susan
    Berbee, Jimmy F. P.
    Verschuren, Lars
    Pieterman, Elsbet J.
    Havekes, Louis M.
    van der Hoorn, Jose W. A.
    Rensen, Patrick C. N.
    Jukema, J. Wouter
    Princen, Hans M. G.
    van Dijk, Ko Willems
    Wang, Yanan
    JOURNAL OF LIPID RESEARCH, 2015, 56 (11) : 2085 - 2093
  • [44] 2D QSAR studies on a series of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one as CETP inhibitors
    Bitam, S.
    Hamadache, M.
    Salah, H.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2020, 31 (06) : 423 - 438
  • [45] Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease
    Pillois, Xavier
    Gautier, Thomas
    Bouillet, Benjamin
    de Barros, Jean-Paul Pais
    Jeannin, Aline
    Verges, Bruno
    Bonnet, Jacques
    Lagrost, Laurent
    JOURNAL OF LIPID RESEARCH, 2012, 53 (06) : 1200 - 1209
  • [46] Exercise Training Favorably Modulates Gene and Protein Expression That Regulate Arterial Cholesterol Content in CETP Transgenic Mice
    Pinto, Paula R.
    da Silva, Karolline S.
    Iborra, Rodrigo T.
    Okuda, Ligia S.
    Gomes-Kjerulf, Diego
    Ferreira, Guilherme S.
    Machado-Lima, Adriana
    Rocco, Debora D. F. M.
    Nakandakare, Edna R.
    Machado, Ubiratan F.
    Correa-Giannella, Maria L.
    Catanozi, Sergio
    Passarelli, Marisa
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [47] Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol A Randomized Controlled Trial
    Nicholls, Stephen J.
    Brewer, H. Bryan
    Kastelein, John J. P.
    Krueger, Kathryn A.
    Wang, Ming-Dauh
    Shao, Mingyuan
    Hu, Bo
    McErlean, Ellen
    Nissen, Steven E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (19): : 2099 - 2109
  • [48] New Insights into Adjuvant Therapy in Renal Cell Carcinoma: Is the Chapter of VEGF Inhibitors Definitely Closed?
    Peyraud, Florent
    Larroquette, Mathieu
    Ravaud, Alain
    Gross-Goupil, Marine
    EUROPEAN UROLOGY, 2021, 80 (03) : 269 - 274
  • [49] The Presence of Cholesteryl Ester Transfer Protein (CETP) in Endothelial Cells Generates Vascular Oxidative Stress and Endothelial Dysfunction
    Wanschel, Amarylis C. B. A.
    Guizoni, Daniele M.
    Lorza-Gil, Estela
    Salerno, Alessandro G.
    Paiva, Adriene A.
    Dorighello, Gabriel G.
    Davel, Ana Paula
    Balkan, Wayne
    Hare, Joshua M.
    Oliveira, Helena C. F.
    BIOMOLECULES, 2021, 11 (01) : 1 - 16
  • [50] Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease A Factorial Mendelian Randomization Study
    Cupido, Arjen J.
    Reeskamp, Laurens F.
    Hingorani, Aroon D.
    Finan, Chris
    Asselbergs, Folkert W.
    Hovingh, G. Kees
    Schmidt, Amand F.
    JAMA CARDIOLOGY, 2022, 7 (09) : 955 - 964